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Abstract
By the early 1970s it had became apparent that the solid phase synthesis of ribonuclease A could 
not be generalized.  Consequently, virtually every aspect of solid phase peptide synthesis (SPPS) 
was reexamined and improved during the decade of the 1970s.  The sensitive detection and 
elimination of possible side reactions (amino acid insertion, Na-trifluoroacetylation, 
Nae-alkylation) was examined.  The quantitation of coupling efficiency in SPPS as a function of 
chain length was studied. A new and improved support for SPPS, the “PAM-resin,” was 
prepared and evaluated.  These and many other studies from the Merrifield laboratory and 
elsewhere increased the general acceptance of SPPS leading to the 1984 Nobel Prize in 
Chemistry for Bruce Merrifield.
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Introduction 
Bruce Merrifield’s concept of an insoluble resin–bound peptide chain, a soluble activated amino 
acid and solvent to effect solid phase peptide synthesis (SPPS), so patently obvious today, 
constituted a new, revolutionary approach to organic synthesis that was eventually recognized 
with a Nobel Prize in Chemistry (1984).  The early research, characteristically understated by 
Bruce in his autobiography,1 provided challenges of heroic proportions, with respect to both 
scientific hurdles and severe resistance by the synthetic organic community. Garland Marshall, 
Bruce Merrifield’s first graduate student (1963 – 1966), recalled the early  “vehement and 
vitriolic” critics in his discussion of SPPS as a paradigm shift.2 Bruce, a man modest in 
demeanor but strong in character, persevered.  The rest, of course, is history.1
My goal as a graduate student in Roger Roeske’s laboratory (Indiana University, 1964-1969) was 
to modify the recently developed SPPS, originally developed for the synthesis of linear peptides, 
to the synthesis of a series of cyclic peptides designed to model the active sites of serine
proteases (chymotrypsin, trypsin).  Suffice it to say that this goal was not totally achieved, 
despite some effort.  The linear precursors were ultimately prepared by SPPS after difficulties in 
coupling non-protein amino acids were resolved. Subsequent purification and cyclization in 
solution provided the desired enzyme model.3-5 My mixed experiences with SPPS prior to 
joining the Merrifield laboratory in 1969 fueled some skepticism regarding the method.  
Consequently, much of my subsequent research in SPPS focused on gaining a better 
understanding of the process and hopefully improving the method so that even severe critics 
would be mollified.  What follows is a record of such efforts. 
Amino Acid Insertions in SPPS 
In SPPS, peptide bonds usually are formed through the reaction of excess N-protected amino 
acid and a coupling reagent such as dicyclohexylcarbodiimide (DCC) with amino acid or peptide 
derivatives of polystyrene.  Brenner stated that acylation of peptide bonds, followed by 
aminoacyl insertion, may be possible under such conditions of “overactivation” 6,7 (Figure 1).  
This presents an interesting paradox in that the use of excess acylation reagents in SPPS to 
efficiently promote peptide bond formation (increase product homogeneity) would also favor 
amino acid insertions (decrease product homogeneity) if Brenner is correct.  As even a low-level 
occurrence of amino acid insertions during SPPS would be unacceptable, it was critical that a 
sensitive detection of this side reaction be developed.  As I was very much aware of product 
heterogeneity in SPPS from my thesis research, I designed a simple model system to test for 
amino acid insertions as a possible source of product heterogeneity in SPPS 8.
It is appropriate, however, to first step back in time and consider what instrumentation was 
available for the sensitive detection of low-level side reactions during the first 15-20 years of 
SPPS.  HPLC, mass spectrometry and high resolution NMR, tools that now enable detection of 
side-products (insertions, deletions, rearrangements) in target peptides, were not readily available 
during this period.  Fortunately, amino acid analyzers employing ion-exchange chromatography 
for the separation and detection of amino acids9 and derivatives10 were common in peptide and 
protein chemistry laboratories.  These instruments could also be used to separate and detect 
mixtures of small peptides,11,12 thereby allowing the determination of relatively low-level side 
reactions (≥ 0.1%) in model peptide systems.  
The model system used to detect possible amino acid insertions during SPPS8 is illustrated in 
Figure 2. Glycine was employed since insertion reactions should be most favored in the absence 
of bulky side chains.  Large excesses (11–22 equiv) of Boc-Gly-OH and DCC were used to 
promote acylation of the peptide bond.  An amino acid analyzer calibrated with H-(Glyn)-OH 
(where n = 1 through 4) was used to detect the products obtained from the acidolytic cleavages 
(HBr-TFA) of peptide resin products 1 and 2.  Cleavage of 1 did not reveal anything larger than 
the expected H-(Gly2)-OH (<0.1% H-(Gly3)-OH and H-(Gly4)-OH).  Cleavage of 2 gave a trace 
peak eluting at the position of H-(Gly4)-OH (0.2%) in addition to the expected H-(Gly3)-OH.  
The presence of H-(Gly4)-OH could result from amino acid insertion as postulated by Brenner 
and/or a “double insertion” reaction observed with glycine derivatives under certain conditions 
of SPPS.13 At any rate, the simple model system showed that amino acid insertions, though 
possible, are not significant side reactions under the usual conditions of SPPS.  
These early results were later substantiated when a sensitive mass spectrometric technique that 
showed no insertion peptides could be detected (< 0.03%) in a 21-residue peptide prepared by 
SPPS.14 Model studies enable us to examine side reactions, whether real or imagined, and 
improve our understanding and use of SPPS.
The Rockefeller University 
Preliminaries
In 1967 I sent letters of inquiry to Robert Schwyzer (ETH, Zurich, Switzerland) and Bruce 
Merrifield regarding postdoctoral research in their laboratories.  The Schwyzer reply was 
negative (sorry, no funding available).  Bruce was positive and asked that what sort of research I 
would like to do in his laboratory.  I sent Bruce a lengthy letter summarizing my work using 
SPPS and gave him my view of future problems and prospects of SPPS.  Bruce liked what he 
read and offered me a position in his laboratory beginning in 1969.
I officially started working in the Merrifield laboratory as a postdoctoral research associate on 
June 2, 1969.  Unofficially, I jumped the gun and started a week earlier (Memorial Day, May 26) 
without remuneration, as I was ecstatic at the prospect of working in the Merrifield laboratory at 
The Rockefeller University and living in New York City. Bruce has described The Rockefeller 
University, his scientific base for over 55 years, in rich detail.1 The high concentration of 
internationally acclaimed scientists on a campus encompassed by only five city blocks on the 
East Side of Manhattan was quite impressive.  Equally impressive was the generous collegiality 
and civility displayed by the senior faculty to young and unknown scientific arrivals on campus –
certainly not what an outsider might expect in New York City.
Beginnings
What to do and where to start? A colleague in the Midwest described a certain famous chemist 
(Nobel Laureate) who exerted total and minute control over his research group.  Every day his 
secretary would post instructions on what reaction was to be run by each postdoctoral researcher.  
The same chemist was also accessible only through appointments with the secretary.  The 
Merrifield laboratory was the antithesis of such an environment.  Bruce was always accessible 
and the only requirement he had was that each graduate student and postdoctoral research 
associate work on a project of mutual interest (mainly to fulfill grant requirements) with as much 
freedom as they were willing to accept. 
Recall that in early 1969 Bernd Gutte and Bruce Merrifield published the use of SPPS to achieve 
the total synthesis of an enzyme with ribonuclease A (Rnase A) activity.15 This achievement, 
coupled with a similar effort by the Merck group using classical solution chemistry16 attracted 
global attention in the scientific and popular press. Gutte’s single-handed achievement, published 
only ten years after the concept of SPPS was recorded in Merrifield’s laboratory notebook, was 
the scientific equivalent of a “grand slam” in baseball (a home run hit with all the bases 
occupied).  How does one match that feat?  It was unclear to me at the time that other proteins of 
comparable size could be prepared in acceptable purity using existing SPPS methodology.  
Consequently, I focused on the synthesis of cyclic peptides by SPPS, a project I had started 
before coming to New York.
Synthesis of cyclic peptides by SPPS
My interest in cyclic peptides began during graduate studies with Roger Roeske when we 
prepared a new class of enzyme models.3-5 Our model incorporates p-aminobenzoyl residues into 
a cyclic peptide to provide a relatively apolar cavity that might serve as a substrate binding site 
in aqueous solution. The peptide bridges between the p-aminobenzoyl residues allow for the 
variation in ring size and placement of functional side chains to form a catalytic site (Figure 3).  
Our synthesis began using classical, solution techniques until Roger visited the Merrifield 
laboratory in 1964 to assess SPPS.  Roger, a forward looking organic chemist who had done 
post-doctoral research with Vladmir Prelog and Vincent du Vigneaud, returned from New York 
enthused about the future of SPPS.  I began to look for ways to use SPPS to provide a convenient 
and rapid synthesis of cyclic peptides.
Polynitrophenol supports
The first demonstration that solid supports could be used to prepare cyclic peptides was provided 
by Fridkin and co-workers17 and is illustrated in Figure 4.  The key steps are (I) attachment of a 
benzyloxycarbonyl (Z) protected peptide to a cross-linked poly-4-hydroxy-3-nitrostyrene resin 3
using a 3-fold excess of Z-peptide and DCC-DMF coupling, (II) deprotection of the Z-peptide 
resin 4 by HBr-HOAc and (III) neutralization of the peptide resin hydrobromide 5 in Et3N-DMF 
with cyclization in the same solvent to produce the cyclic peptide product 6.  Steps (I) and (III)
are problematic.  The coupling of Z-peptide to the nitrophenol support in step (I) using DCC-
DMF will be accompanied by racemization via the well-known formation of oxazolones 
observed during the activation and coupling of peptide fragments.  Step (III) features the 
neutralization and cyclization of a polymeric peptide nitrophenyl ester.  The release of a peptide 
oxazolone from the polymer support prior to cyclization cannot be ruled out.  The formation of a 
peptide oxazolone would of course nullify any advantage of site isolation as a peptide oxazolone, 
if formed, will be in solution and free to racemize as well as cyclize, dimerize and polymerize. 
Initially, the use of peptide  derivatives of cross-linked polymers to favor intramolecular 
reactions (cyclizations) over competing oligomerization was thought possible as the reactant 
molecules were considered attached to the polymer at relatively large intermolecular distances 
thereby providing a situation termed as “infinite dilution at finite concentration”18.  It was shown 
by others that copolystyrene-2% divinylbenzene is not a rigid polymer in which specific sites 
maintain their separation during reaction.19 For example, when only 0.5% or 1 out of 200 phenyl 
residues in copolystyrene-2% divinylbenzene are substituted with carboxymethyl groups, 50% of 
the carboxymethyl groups are available to form inter-site symmetrical anhydrides.  This research, 
in addition to other work cited by the authors, led to the conclusion that reports which imply site 
separation must be explained on the basis of favorable kinetic relationships between the desired 
reactions and competitive reactions.  However, discussions regarding kinetics, site isolation 20 or  
combinations of both factors  detract from the practical advantage that polymer-supported 
syntheses of cyclic peptides have over  syntheses carried out in solutions.  This advantage has 
motivated subsequent workers to explore extensions of Fridkin's findings for the preparation of 
cyclic peptides by SPPS.21
General approach for the synthesis of cyclic peptides by SPPS 
A general approach to preparing cyclic peptides by SPPS is presented as a generalized scheme in 
Figure 5.  The scheme combines the synthesis of a linear peptide followed by cyclization.  The 
synthesis of the linear peptide begins with the attachment of the carboxyl group of the C-terminal 
amino acid to the polymer support.  Schemes utilizing the attachment of various amino acid side-
chains to a polymer support22 represent a less general approach and are not discussed here.  The 
linker attached to the C-terminal amino acid serves a dual function.  It must be stable to the 
conditions of SPPS that involve repeated couplings, deprotections and base neutralizations 
during the step-wise synthesis of the linear peptide.  Then, upon completion of the linear 
sequence, the activated peptidyl-linker must be susceptible only to an intramolecular attack by 
the amino group of the N-terminal amino acid of the peptide to yield the desired cyclic peptide 
under conditions that preclude oxazolone formation and possible racemization.  How can this be 
accomplished?  
Mercaptophenol supports
Consider three polymer supports used for the synthesis of cyclic peptides (Figures 6-8). Support 
7, prepared by the reaction of 4-mercaptophenol with chloromethylpolystyrene-2%-
divinylbenzene 23,24 is acylated with a Boc-amino acid using DCC or mixed anhydride coupling 
to provide derivative 8 which is elongated by conventional SPPS to the desired protected peptide 
derivative 9 (Figure 6).  Oxidation of 9 with 3-chloroperbenzoic acid yields the corresponding 
sulfone derivative 10 which is deprotected (HCl-HOAc) to give the peptide hydrochloride 
derivative 11. Suspension of 11 in excess Et3N-DMF for 18 hours provides cyclic peptide 12.  
The synthesis in Figure 6 extends the approach in Figure 5 in using a polymer support to effect 
both synthesis of the linear peptide sequence and subsequent cyclization to cyclic peptide.  
However, both approaches expose polymeric peptide active esters to Et3N-DMF during 
cyclization reactions (Figure 4: 5 -> 6 and Figure 6: 11 -> 12 ). The potential for oxazolone 
formation and subsequent racemization prior to cyclization must be recognized and evaluated.
Arylhydrazine supports
Wieland and coworkers,25 in a very thorough and detailed paper,  extended the work of earlier 
researchers26,27 in examining the use of peptide derivatives of phenylhydrazine in solution and 
solid phase chemistry.  The aryl hydrazine support 13 was prepared by the esterification of Boc-
4-aminobenzoic acid with chloromethylpolystyrene-2%-divinylbenzene (Figure 7). Deprotection 
of 13 and elongation using Boc/benzyl chemistry employed earlier on mercaptophenol support23
(Figure 6) gave protected peptide derivative 14.  Transesterification of 14 (Et3N-CH3OH) 
afforded Boc-hexapeptide methyl ester 15. Deprotection of 14 and 15 provided the 
corresponding peptide trifluoroacetates 16 and 17, which were treated with NBS and pyridine in 
THF to give peptidyl-diazenes 18 and 19. Treatment of a THF solution containing 19 (high 
dilution at ≈ 1 mM) with triethylamine (~ 60 equiv.) for 72 h gave cyclic peptide 20 in 10% yield 
after detection and isolation from a thin layer chromatogram calibrated with an authentic sample 
of 20 prepared by alternative synthetic routes.  Treatment of resin- supported peptidyl-diazene 18
in an analogous fashion gave a crude reaction mixture with 20 detectable on a thin layer 
chromatogram but attempts to isolate 20 failed. Similarly, attempts to cyclize a linear peptide 
having the sequence of antaminide (cyclic decapeptide from the poisonous mushroom Amanita 
phalloides) failed to produce an isolable yield of antaminide using the same aryl hydrazine 
support.  In contrast, antaminide is obtained in 25% yield when the linear precursor is cyclized in 
solution.28 While the SPPS of linear peptide sequences on the aryl hydrazine support proceeded 
without incident, cyclizations went poorly, if at all, when compared with analogous cyclizations 
in solution.  My attempts to cyclize peptides from peptidyl-diazene resins were also not 
encouraging as low yields of partially racemized cyclic products were invariably observed.  It 
should be noted that earlier workers observed some racemization  (≤ 4.5%) when peptidyl-
hydrazides were oxidized and used in peptide coupling reactions.26,27 Clearly, Wieland 
demonstrated that the use of aryl hydrazine supports for the SPPS of cyclic peptides was 
contraindicated25 and more promising alternatives should be investigated.
It should be observed, however, that 31 years later Rosenbaum and Waldmann reinvestigated 
Wieland's system and were able to prepare cyclic peptides by SPPS using aryl hydrazine 
supports.29 One deciding factor appears to be an efficient purification tool (HPLC) not available 
to Wieland in 1970.  Accordingly, a cyclic hexapeptide was prepared and isolated in 19% yield 
while a cyclic heptapeptide (isolated from the marine organism Stylotella aurantium) was 
obtained in 7% overall yield.  The claim that intramolecular cyclization from the peptidyl-
diazene support proceeds without racemization bears scrutiny, however.  The possibility of 
partial racemization of the C-terminal amino acid after oxidative conversion to the peptidyl-
diazene was modelled using Fmoc-L-Ala attached to an arylhydrazine support.  Oxidation of the 
Fmoc-L-Ala-hydrazide support to the acyldiazene derivative followed by reaction with H-L-Phe-
OMe gave only Fmoc-L-Ala-L-Phe-OMe (analysis by chiral HPLC) which "unambiguosly 
proved that epimerization had not occurred 29".  Agreed, but only in the model dipeptide system 
investigated.   It is well-known in peptide chemistry that urethane-protected amino acids couple 
without epimerization and segment coupling of peptides not containing C-terminal glycine or 
proline couple with with epimerization to some degree.30 The preparation, separation and 
detection of a cyclic peptide target and its corresponding diastereoisomer will help determine to 
what extent peptidyldiazenes epimerize during intramolecular cyclizations.
Catechol supports
The supports described above (Figures 4, 6 and 7) have inherent shortcomings, especially with 
respect to racemization potential during peptide cyclizations.  Consequently, the preparation and 
use of peptide monoesters of catechol to prepare cyclic peptides via SPPS seemed very 
promising.  The remarkable resistance of peptide monoesters of catechol to racemization,31,32
coupled with the high reactivity of 2-hydroxyphenyl esters when compared to the corresponding 
phenyl esters, led to their use for the preparation of peptide polymers.33 Use of the monobenzyl 
ether of catechol allows the synthesis of relatively inert peptide phenyl ester monomers. Removal 
of the benzyl ether ("safety catch") provides the more reactive peptide monoesters of catechol 
used in polymerization reactions.  This work suggested a route to the SPPS of cyclic peptides 
that might overcome the drawbacks of the approaches described in Figures 4, 6 and 7.   
The new support would feature a catechol monobenzyl ether (o-benzyloxyphenol) attached to the 
usual copolystyrene-divinylbenzene support employed in SPPS (Figure 8). Kun34 had prepared 
hydroquinone-quinone redox polymers through the Friedel-Crafts alkylation of hydroquinone 
and derivatives (1,4-diacetoxybenzene and 1,4-dimethoxybenzene) using chloromethylated 
polystyrene resins.  The reaction is carried out in refluxing ethylene dichloride in the presence of 
zinc chloride and can be followed by the evolution of hydrogen chloride. 
Analogously, catechol reacts with chloromethylated polystyrene to give catechol resin 21 while 
use of o-benzyloxyphenol32 should give the monobenzyl-catechol support 22 (Figure 8).  
Acylation of 22 with a Boc-amino acid will give 23 and peptide elongation using Boc/benzyl 
chemistry provides peptide derivative 24.  Treatment of 24 with HBr-HOAc removes the N-Boc 
and O-benzyl protecting groups to give the peptide-catechol monoester 25 which is reacted in 
Et3N-DMF to provide cyclic peptide 26 and catechol resin 21.  Eventually it was found that the 
scenario in Figure 8 could not be realized due to the conditions of the Friedel-Crafts reaction 
used to prepare 22.  While reaction of o-benzyloxyphenol with chloromethylated polystyrene 
may initially provide support 22, the release of hydrogen chloride in refluxing ethylene 
dichloride will convert support 22 to the debenzylated catechol resin 21 (Figure 9).  Subsequent 
efforts to selectively protect one of the two hydroxyl functions in resin 21 were unsuccessful. 
Monoacylated catechols can be obtained from the corresponding cyclic sulfite derivatives.35 This 
allows the preparation of peptidyl-catechol derivatives 25 for use in cyclization studies (Figure 
10).  The use of Boc-Pro3-OH to form the 9-atom cyclo-[Pro3] provides the most meaningful 
model as oxazolone intermediates cannot be formed during the cyclization reaction.   Rothe first 
prepared cyclo-[Pro3] in 88% yield through the cyclization of H-Pro3-OH in solution using the 
phosphite and p-nitrophenyl ester methods 36.  Preparations of cyclo-[Pro3] using the Pro3-
catechol resin 25, the H-Pro3-p-nitrophenyl resin 26 and H-Pro3- p-nitrophenyl ester 27 are 
compared in Figure 10.  H-Pro3-catechol resin 25 afforded cyclo-[Pro3] in ≤ 5 % yield, while 26
furnished cyclo-[Pro3] in 20-30% yield and 27 gave cyclo-[Pro3] in 36% yield in an non-
optimized solution synthesis.  The low potential for peptide cyclizations to occur on catechol 
resin supports was confirmed in other model systems.37 Jones, in later reports, also recognized 
the sluggish reactivity of o-hydroxyphenyl esters when compared with ordinary active esters ( p-
nitrophenyl, pentachlorophenyl or succinimido), especially in dipolar aprotic solvents (DMF, 
DMSO) where aminolysis is even retarded somewhat.38,39 Suffice it to say that the cyclic peptide 
project that I brought to New York became inordinately time consuming (when to stop?), 
inconclusive (just one more model study?) and less than satisfying.  At any rate, there were 
other, more pressing issues to address in SPPS.
Amino Acid Insertions Revisited
Bruce has contrasted his objectives and tactics in the initial development of SPPS with later 
refined studies (see p. 177 in reference 1).  The first stage was a qualitative effort to put together 
chemistry that would provide a viable scheme for SPPS. The next stage involved obtaining semi-
quantitative data to demonstrate that the technique was basically satisfactory. The last stage 
involved highly quantitative experiments designed to detect and eliminate low-level side 
reactions.  An example of the last stage is illustrated in a study utilizing urethane-protected 
amino acids and mixed anhydride couplings by Merrifield, Mitchell and Clarke.13 In 1973 Bruce 
was still able to spend some time in the laboratory and, together with Joan Clarke, one of Bruce's 
many outstanding technician assistants (see p. 97 in reference 1), we explored the possibility of 
amino acid insertions occurring in SPPS during mixed anhydride couplings. The Na-2-(4-
biphenylyl)-propyloxycarbonyl (Bpoc) derivatives of Gly, Ala and -Leu were activated (ethyl 
chlorocarbonate and triethylamine in methylene chloride, 0° C) and subsequently used in 
coupling reactions (25° C) with H-Val-resin to produce the expected H-Leu-Ala-Gly-Val-OH as 
well as a by-product identified as H-Leu-Ala-Gly-Gly-Val-OH (4%).  Initially, we thought this 
unexpected product arose from acylation of the urethane nitrogen of Bpoc-Gly-Val-resin and/or 
acylation of the amide nitrogen of Bpoc-Gly-Val-resin and subsequent insertion as postulated by 
Brenner.6,7 Mitchell and Roeske8 had earlier demonstrated that acylations of urethane and amide 
nitrogens do not significantly occur in a system employing Boc-Gly-OH and DCC couplings 
(Figure 1).  The same finding was made in this study when it was shown that Bpoc-Gly-Val-
resin was not acylated at the urethane nitrogen by symmetrical or mixed anhydrides of Bpoc-
Gly, by Bpoc-Gly activated with dicyclohexylcarbodiimide, or  by leucine-N-
carboxyanhydride.13 It was determined that urethane acylation occurred before the activated 
intermediate (Bpoc-Gly-OCO2Et) was coupled to the H-Val-resin in the original synthesis. The 
mechanism for this side reaction involves disproportionation of the mixed anhydride of Bpoc-
Gly-OH to the symmetrical anhydride, and intramolecular rearrangement of the latter to form N-
Bpoc-Na-(Bpoc-Gly)-Gly-OH, which is subsequently activated by anhydride  interchange and 
reacts with Val-resin to yield N-Bpoc-Na-(Bpoc-Gly)-Gly-Val-resin.13 Rearrangement is 
dependent on the temperature and time of mixed anhydride formation and is undetectable after 
activation at -15o C  (10 min) and coupling at -15o C (2 h).  No urethane acylation (< 0.1 mol %) 
was observed  during coupling of  Bpoc-Gly-OH with Val-resin when DCC was used under 
standard  SPPS conditions.
N-Alkylation during the Acidolytic Cleavage of Urethane Protecting Groups
The motivation for this project came from a report of 20% N-alkylation during the acidolytic 
cleavage of a Bpoc group from a derivative of hydroxylamine.40 An analogous N-alkylation 
during the acidolytic cleavage of Boc groups during SPPS could offer an explanation of the rise 
in background observed with picrate monitoring during SPPS.41
The deprotection of Na-Boc-peptide-resin 28 to yield small quantities (~ 0.1-1%) Na-tert-butyl 
peptide 29 during each deprotection step is undesirable because it would give rise to terminated 
chains or N-alkyl peptides (Figure 11). Also, the production of a variable amount of hindered 
secondary amines would give corresponding increases in background when picrate41 or 
chloride42 monitoring methods were used to follow the course of a solid phase peptide synthesis.  
I devised a model system (Figure 12) and found no evidence of Na-tert-butylation (< 0.05%, 
32).43 The presence of 0.17% H-Gly-Lys(Bzl)-OH 34, however, indicated that N-benzylation had 
occurred during partial deprotection of the Ne-benzyloxycarbonyl (Z) group when 31 was treated 
in TFA-CH2Cl2.  When Boc-Lys(Z)-resin 30 was treated with a variety of acidic cleavage 
reagents used to deprotect Boc-peptides, H-Lys(Bzl)-OH (35, ≤ 0.88%)  was found.  The extent 
of H-Lys(Bzl)-H production depended on the nature of the reagent and whether a carbonium ion 
scavenger was used.  This side reaction did not occur when more acid-stable Z protecting groups 
such as the 2,4-Cl2-Z group44 were used.  N-Benzylation  (0.47- 3.26%) also occurred under 
conditions of complete deprotection with Z-Gly-OH, Bzl-Lys-OH and H-Lys(Bzl)-OH in
refluxing TFA or ambient TFMSA-TFA.  No N-benzylation (< 0.1%) could be detected when 
amino acid resins or free amino acids containing Z protecting groups were cleaved with 
anhydrous HF.  In summary, Na-tert-butylation was not observed when model experiments using 
the Boc protecting group under conditions of SPPS were employed.  N-Benzylation, a novel side 
reaction, was observed when Z groups were removed from Z derivatives of Gly and Lys by TFA 
or TFMSA-TFA.  This side reaction was avoided when a more acid-stable Z protecting group 
was used for lysine.
Quantitation of synthetic efficiency in solid phase peptide synthesis as a function of chain 
length
When Bruce began working in the Woolley laboratory in 1949 each postdoctoral fellow worked 
on separate projects and never as a group on a single problem (see p. 42 in reference 1).  
Woolley assigned research topics and discussed results on a frequent basis.  When I arrived in 
1969 one could propose their own research plans within the framework of SPPS, and although 
Bruce was never demanding with respect to the pace of research, he was always accessible for 
advice and consultation.  Also, in the 1970s more of the individual researchers in the laboratory 
began teaming together on problems of mutual interest.  An example of this is found in the 
development of the aminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin (-O-CH2-PAM-resin) 
or "PAM-resin" for short.45,46 The PAM-resin was originally developed as part of a program to 
examine synthetic efficiency in solid phase peptide synthesis as a function of chain length, which 
will now be discussed.
Since the early days of the solid-phase there had been a general feeling that there must be resin-
imposed steric limitations to stepwise solid-phase peptide synthesis.47 Some workers thought that 
reactions will be less efficient close to the polymer backbone48 while others thought that there 
would be significant declines in yields as the peptide is elongated, due to temporary steric 
occlusion of peptide chains within the polymer network.49 In 1971 I proposed an approach that 
would allow testing of coupling or synthetic efficiency in SPPS.  A generalized version of this 
approach is given in Figure 13 where a well-characterized model peptide is synthesized at 
increasing distances from the solid support by using a polyamino acid spacer of varying lengths.  
The model peptide Leu-Ala-Gly-Val is used as a chromatographic system that separates all 
possible deletion and termination peptides from the parent peptide at a 0.1% detection level.13
Use of an aryl hydrazine resin
An early chemical formulation of the approach outlined above (Figure 13) is presented in Figure 
14. Chloromethylated polystyrene is reacted with the cesium salt of Boc-Phe-OH to provide the 
starting Boc-Phe resin which is deprotected, neutralized and reacted with Boc-Lys(Tos)-OH and 
DCC to provide Boc-Lys(Tos)-Phe resin.  Repetitions of deprotection, neutralization and 
coupling (n= 0, 10, 20 ...) provide peptide spacers of varying chain lengths designated as Boc-
[Lys(Tos)]n+1-Phe-resin 36. Valine, the C-terminal amino acid of the model peptide is then added 
as part of a linker or handle comprising Boc-Val and p-hydrazinobenzoic acid
(PHBA).  Acylation of 36 with Boc-Val-PHBA provides 37 which is subsequently elongated by 
SPPS to give support 38.  Cleavage of 38 by oxidation in the presence of  acetic acid-water
followed by deprotection should afford H-Leu-Ala-Gly-Val-OH and related deletion peptides.  
Preliminary studies on the oxidative cleavage of a Boc-Leu-Val-PHBA-Phe-resin provided H-
Leu-Val-OH in low yield that contained ~10 % of the H-Leu-D-Val-OH diastereoisomer. The 
production of target peptide, deletion peptides, target peptide diastereoisomer and deletion 
peptide diastereoisomers would clearly overwhelm the analytical system used for the detection of 
H-Leu-Ala-Gly-Val-OH  and related deletion peptides.13 The combination of an inefficient 
oxidative cleavage coupled with racemization clearly indicated the need for better chemistry.  
Other iterations of the scheme in Figure 12 were tested after the aryl hydrazine experiments and 
found lacking.  Rather than trying to optimize a less than promising system, it was decided not to 
pursue this project, at least until some better ideas surfaced.  Work on some of the projects 
described above, especially cyclic peptides, was continued. 
Phenylacetamidomethyl(PAM) resin - early phase  
The Merrifield laboratory had numerous visitors seeking practical laboratory training in SPPS.  
Virtually every member of the laboratory took turns at instructing visitors on a one to one basis 
for one to two week periods.  Late in 1973 Bruce described an exchange program sponsored by 
the National Academy of Sciences and asked if I would like to take on a Russian scientist for 4 
months beginning in 1974.  I initially hesitated, thinking I didn't have time to entertain a possible 
science bureaucrat who hadn't worked in a laboratory for years.  I finally agreed to do it as my 
small contribution to easing American - Soviet relations during the Brezhnev era of the Cold 
War.  My fears regarding Mikail Nikolaich Ryabtsev were unfounded as he was a hands-on 
chemist, eager to work and learn new techniques.  It was also time to launch another attack on 
the coupling efficiency problem via a PAM resin.  As he lived on campus and I lived across the 
street it was easy to mesh our schedules, which usually meant working in the laboratory 
Mondays through Saturdays with most evenings included.  Sundays were reserved for touring 
New York City, visiting museums, etc. As I felt responsible for Mikail's personal safety I made 
certain that he knew to avoid the South Bronx and similar areas having high adventure potential.  
He was soon on his own with no untoward incidents to report.  Back to the lab and how to 
execute the general approach outlined in Figure 13?
The scheme in Figure 15 evolved after related variations tested in the laboratory showed little 
promise.  The insertion of a phenylacetamidomethyl (PAM) bridge between the polystyrene 
matrix and peptide sites was predicted to make the resulting peptide esters significantly more 
stable (between 25 and 400 times) than peptide chains bound to the then commonly used 
oxymethyl-poly(styrene-co-divinylbenzene) resin (see p.155 in reference 1). The key to the 
scheme is Boc-valyl-4-(oxymethyl)phenylacetic acid 39 which is initially used to acylate 
aminomethyl-poly(styrene-co-divinylbenzene) resin 40.  Aminomethyl-resin 40 was prepared by 
the hydrazinolysis of phthalimidomethyl-resin that was obtained from the reaction of potassium 
phthalimide with chloromethyl-resin.45 The acylation of 40 with 39 provides 41 which is
elongated by SPPS to give tetrapeptide resin 42. Acidolytic cleavage (HF) of 42 will yield H-
Leu-Ala-Gly-Val-OH and related deletion peptides.  A second cycle of H-Leu-Ala-Gly-Val-OH 
synthesis begins with Boc-deprotection of 42 followed by neutralization and coupling with 39 to 
provide the new Boc-Valyl-4-(oxymethyl)phenylacetamidomethyl resin 43 while terminating the 
tetrapeptide resin 42 obtained from the first synthetic cycle.  Resin 43 is elongated in the usual 
fashion to provide resin 44 which upon cleavage should provide H-Leu-Ala-Gly-Val-OH and 
related deletion peptides from only the second cycle.  Additional cycles (n) provide resin 45 
containing [Leu-Ala-Gly-Val-4-(oxymethyl)phenylacetamide]n+2 resin.  The yields of H-Leu-
Ala-Gly-Val-OH and deletion peptides are determined after every synthetic cycle to provide 
information on coupling efficiency as a function of peptide chain length from the polystyrene 
matrix.
The synthesis of Boc-valyl-4-(oxymethyl)phenylacetic acid 39, a key component in our scheme, 
was problematic.   Briefly stated, the reaction of Boc-Val-OH cesium salt with 4-
(chloromethyl)phenylacetic acid50 yields 39 in addition to unreacted 4-(chloromethyl)-
phenylacetic acid and polymers deriving of 4-hydroxymethylphenylacetic acid containing 
variable amounts of esterified Boc-Val . Attempts to purify 39 by crystallization, by column 
chromatography on Sephadex LH-20 or silica gel, and by countercurrent distribution were not 
entirely satisfactory.  Ultimately, after considerable trial and error, 39 was obtained  analytically 
pure after repeated preparative layer chromatography in 9: 1 hexane-AcOH and isolation as a
cyclohexylammonium salt.  A general, and more convenient preparation of Boc-aminoacyl-4-
(oxymethyl)phenylacetic acids was developed later and reported in a subsequent PAM-resin 
paper.46
An alternative scheme for the general preparation of Boc-aminoacyloxymethyl-PAM-resins is 
given in Figure 16 using Boc-Val-4-(oxymethyl)phenylacetamidomethyl-resin 41 as an example.  
4-(Acetoxymethyl)phenylacetic acid 46, obtained from the reaction of 4-(chloromethyl)-
phenylacetic acid with sodium acetate, is reacted with aminomethyl-resin 40 to provide 4-
(acetoxymethyl)phenylacetamidomethyl-resin 47.  Hydrazinolysis of 47 provides 4-
(hydroxymethyl)phenylacetamidomethyl-resin 48 which is acylated with a Boc-amino acid, in 
this case Boc-Val, to provide Boc-Val-4-(oxymethyl)phenylacetamidomethyl resin 41 which can 
be elongated by SPPS to give tetrapeptide resin 42 (Figure 15).  
The third route for preparation of Boc-aminoacyloxymethyl-PAM-resins shown in Figure 17 
employs 4-(halomethyl)phenylacetic acid (X = Cl, Br) 49. This route furnished a model 
tetrapeptide in less satisfactory purity than did the previous routes.  Alhough the predominant 
reaction was N-acylation of the aminomethyl-resin by the DCC-activated 4-
(halomethyl)phenylacetic acid to give 4-(halomethyl)phenylacetamidomethyl resin 50 , N-
benzylation of some aminomethyl sites  by the halomethylphenylacetic acid may also have 
occurred.  In addition, halomethyl-PAM sites that did not react with the first Boc-amino acid 
may have participated in undesirable benzylation reactions later in the synthesis. A report by
Sparrow 51 described the preparation of a Boc-aminoacyl-4-(oxymethyl)phenylacetamido-11-
undecanoylaminomethyl-resin in a variation of Figure 17. The use of the aminoundecanoyl 
spacer was thought necessary to overcome possible steric hindrance by the polystyrene backbone 
to peptide synthesis52 but the acid stability of this resin was not investigated.
In addition to the H-Leu-Ala-Gly-Val-OH test peptide, a deca-lysyl-valine test peptide was  
prepared using a Boc-Val-oxymethyl-PAM-resin.  The crude product obtained after HF cleavage 
was analyzed by ion-exchange chromatography on carboxymethylcellulose and the 
chromatogram was nearly identical to a chromatogram obtained earlier using Boc-Val-OCH2-
resin.53 We compared the acid stabilities of tetrapeptide-OCH2-PAM-resin 42 with a 
conventional tetrapeptide-OCH2-resin13 in 50% TFA-CH2Cl2 and found that the loss of peptide 
chains followed apparent first order kinetics for both resins.45 The H-Leu-Ala-Gly-Val-OCH2-
PAM resin was found to be about 100 times more stable than the conventional Leu-Ala-Gly-Val-
OCH2-resin. The loss of peptide chains per 20-min Na-deprotection step was calculated to be 
0.7% for the usual resin but only 0.007% for the PAM-resin. When assembly of the desired 
peptide is complete, however, the benzyl ester bond of the PAM-resin is readily cleaved in high 
yield (87%) by treatment with anhydrous HF. Thus the advantages of increased acid stability of 
the anchoring bond can be achieved without sacrificing the high yield of peptide obtained by HF 
cleavage. The greater acid stability of the PAM-resin will result in substantially higher yields of 
large polypeptides such as ribonuclease (124 residues) where the loss of peptide chains from the 
support should be reduced from 80% to about 4%. Also, the late initiation and growth of shorter 
peptide by-products on the resulting hydroxymethyl sites will be decreased.54
Phenylacetamidomethyl(PAM) resin - intermediate phase
Colleagues and I sometimes wondered what criteria were used to select members of the 
Merrifield laboratory.  Strangely enough, no one ever bothered to ask Bruce the question, "why 
am I here?" Bruce has commented on the role of chance in science and luck being a large factor 
in the selection of problems (see p. 248 in reference 1) I suspect similar considerations were in 
play in determining how Bruce staffed the laboratory.  Equally important, Bruce's impeccable 
integrity and decency provided the foundation on which the laboratory operated.  I felt extremely 
privileged to work with such congenial and competent persons whether they were the glassware 
washer, secretary, technicians, students or postdoctoral fellows.  I can list only a few, some in 
cited publications, others in work described in this paper.  At any rate, I think both Bruce and 
SPPS were very fortunate to have Stephen (Steve) B. H. Kent and James (Jimmy) P. Tam join 
the laboratory as postdoctoral research associates. Although we overlapped at Rockefeller 
(Mitchell, 1969-77; Kent, 1974-81; Tam, 1976-92), Steve and I didn't begin working together on 
problems of mutual interest until 1976 and interactions with Jimmy were limited to stimulating 
discussions regarding future directions and improvements in SPPS.  Kent and Tam have 
developed remarkably prolific, independent careers in peptide and protein chemistry since their 
beginnings in the Merrifield laboratory in the 1970s.
It was apparent from earlier work on PAM resin (vide supra)45 that this support would provide 
larger peptides in higher yields and purity than the conventional peptidyl-OCH2-resin.  A more 
convenient preparation of PAM resin was needed and the first task involved an improved 
preparation of the aminomethyl-resin 40 mentioned earlier (Figures 15-17).  The use of either 
hydroxymethyl- or chloromethylphthalimide with a Friedel-Crafts catalyst to effect direct 
amidomethylation of the unsubstituted polystyrene matrix via a Tscherniac-Einhorn reaction55
provides a phthalimidomethyl-resin which upon hydrazinolysis provides the desired 
aminomethyl-resin 40.56 This preparation of 40 involves one less step than the earlier preparation 
45 and eliminates the need for chloromethylated polystyrene and the carcinogenic chloromethyl 
methyl  ether used in its preparation.
The original synthesis of Boc-Val-4-(oxymethyl)phenylacetic acid 39 from Boc-Val and 4-
(chloromethyl)phenylacetic acid was tedious and could not be generalized for the preparation of 
other Boc-aminoacyl-4-(oxymethyl)phenylacetic acids.45 Martin Engelhard, a knowledgeable 
organic chemist from Germany with Old World savoir faire, joined Steve and I in developing a 
convenient and general preparation of Boc-aminoacyl-4-(oxymethyl)phenylacetic acids for use 
in PAM resins.
Our preferred general preparation of Boc-aminoacyl-4-(oxymethyl)phenylacetic acids (Figure 
18) begins with the reaction of 4-(bromomethyl)phenylacetic acid 4951,57 with 
bromoacetophenone to provide 4-(bromomethyl)phenylacetic acid phenacyl ester 51.  
Condensation of a Boc-amino acid salt with 51 yields the Boc-aminoacyl-4-
(oxymethyl)phenylacetic acid phenacyl ester 52. The phenacyl group is removed by Zn-AcOH 
acid reduction at room temperature, without cleaving the Boc or benzyl ester, to give the desired 
Boc-aminoacyl-4-(oxymethy1)phenylacetic acid 53. The route shown in Figure 18 can be used 
for a variety of protected amino acids as most of the commonly used protecting groups are stable 
to the reductive cleavage conditions. We also explored the use of 4-(bromomethyl)phenylacetic 
acid N-hydroxysuccinimide ester hoping that the N- hydroxysuccinimide ester would serve as a 
carboxyl protecting group during the formation of  the benzyl ester bond, and then serve as an 
active ester to allow the acylation of aminomethyl-resin to give Boc-aminoacyl-OCH2-PAM-
resin.  Unfortunately, the reaction of Boc-Val-OH cesium salt with 4-(bromomethyl)phenylacetic 
acid N-hydroxysuccinimide ester proceeded poorly and yielded a multiplicity of products in 
addition to the desired Boc-valyl-4-(oxymethyl)phenylacetic acid N-hydroxysuccinimide ester 
which could not be isolated as a pure compound. 
An improved preparation of Boc-aminoacyl-4-(oxymethy1)phenylacetic acids was developed  by 
Tam and Kent by using potassium fluoride as the base in the two esterification reactions in 
Figure 18.58 The stage was set to now utilize PAM resins for the synthesis of larger peptides.
Phenylacetamidomethyl (PAM) resin - mature phase
The work described for the early and intermediate phases of PAM resin development45,46,56,58 set 
the stage for utilizing PAM resins in the synthesis of larger peptides.  This work was entrusted to 
other capable hands as it was time to heed Horace Greeley's admonition, "Go West, young man,"
leave Rockefeller University (1969-77) and return to California after a 16-year absence (military 
service, graduate and postgraduate work). The quantitation of synthetic efficiency in solid phase 
peptide synthesis as a function of chain length, the initial raison d'etre for PAM resin, was 
extended and completed by Sarin and Kent using the scheme in Figure 15 as a starting point.59
Briefly stated, the model test peptide H-Leu-Ala-Gly-Val-OH was synthesized by SPPS at 
increasing distances from a 1% cross-linked polystyrene support. The efficiency of the synthesis 
was evaluated by quantitatively measuring the deletion peptides H-Leu-Ala-Val-OH and H-Leu-
Gly-Val-OH that were produced during the synthesis of the tetrapeptide.13 The insertion of an 
oxymethylphenylacetyl group between the test peptide and the peptide chains used to provide 
spacers from the support made it possible to selectively evaluate the quality of the tetrapeptide 
without interference by the spacer.  Low and constant levels of deletion peptides were found and 
no significant effect of distance from the support or of peptide loading on the synthetic efficiency 
could be detected up to a chain length of 60 residues and a peptide-to-resin weight ratio of 4 to 1. 
The observation of high synthetic efficiency even up to 60 residues and 80% peptide content 
clearly demonstrated the lack of intrinsic limitations to stepwise solid-phase synthesis over an 
extreme range of peptide loading. This study demonstrated that the poor synthetic results 
obtained in certain applications of SPPS by other laboratories have chemical rather than resin-
related physical explanations. 
The synthesis of mammalian glucagon, a 29-amino acid peptide hormone secreted by the 
pancreas, was considered a landmark achievement when Erich Wünsch and coworkers described 
the preparation of fully active, crystalline material in 1968.60 The synthetic glucagon was 
prepared in solution using classical fragment condensation methods by a large, skilled team over 
a period of several years.61 Wünsch in a review on the synthesis of naturally occurring 
polypeptides, reflected on the problems of synthetic peptide research circa 1971.48
Using the glucagon synthesis as a model, he contended that conventional (solution) synthesis 
with maximum use of protective groups allows the synthesis and subsequent coupling of peptide 
fragments with almost total avoidance of by-products.  This approach would be considered very 
good for the synthesis of peptide sequences containing up to 30 amino acid residues and, barring 
solubility problems, the maximum sequence possible would be 30-50 amino acid residues. A 
large portion of the review is devoted to solid-phase synthesis, which despite the surprising 
simplicity of the idea and the possibility of automation, exhibits "inborn defects" with respect to 
peptide synthesis and inadequacy of analytical methods to monitor synthetic progress. Wünsch 
concluded that SPPS in 1971 was "unsuitable for the satisfactory synthesis of higher natural 
peptides (with more than 15 amino acid residues)."  Benefiting from hindsight,1 we can toss 
much of Wünsch's litany of concerns and faults with SPPS into the dustbin of peptide history. 
Again, using the glucagon synthesis as a model, the resources and manpower required for the 
solution synthesis of glucagon analogs to support an extensive study of structure-activity 
relationships would be enormous and could not be undertaken.
A cursory reading of Bruce's scientific autobiography1 and this paper will inform the reader that 
the Merrifield laboratory was not sitting on its collective hands after the 1969 publication of 
Gutte's synthesis of an enzyme with Rnase A activity.15 In addition to considerable 
methodological work on SPPS, parallel synthetic efforts on biologically active peptides such as 
glucagon were being pursued.  A renewed interest in glucagon physiology and its role in diabetes 
mellitus developed in response to the bihormonal hypothesis of Unger.62 Questions about the 
mechanism of action of glucagon could best be answered by total synthesis of the hormone and 
of appropriate analogues.  Recall that glucagon, with its 29 amino acid sequence containing 
many trifunctional amino acids, was considered by Wünsch to be beyond the capability of SPPS 
with its many "inborn defects".48 Svetlana Mojsov, one of the many talented graduate students 
in the Merrifield laboratory, took up the challenge.   
The first stepwise solid phase synthesis of mammalian glucagon was briefly described in 1977 as 
part of a report on recent developments in SPPS.63 The detailed synthesis that was reported later 
described the preparation of fully active, crystalline glucagon using an alkoxybenzyl alcohol 
resin (Wang resin) with the biphenylylisopropyloxycarbonyl group (Bpoc) used for temporary a-
amino protection.64 The crude synthetic material was purified by gel filtration and ion-exchange 
chromatography followed by crystallization of the 29-residue hormone from water.  The 
synthetic glucagon was homogeneous and indistinguishable from natural bovine glucagon by gel 
electrophoresis, ion-exchange chromatography, reverse-phase high-pressure liquid 
chromatography, fluorescence spectroscopy, amino acid analysis and it was fully active in the 
rabbit hyperglycemia assay.
An improved synthesis of crystalline mammalian glucagon was subsequently developed by 
Svetlana using a PAM resin with Na-t-butoxycarbonyl and benzyl-based side-chain protection 
for most of the trifunctional amino acids.65 The cyclohexyl-protecting group was used for the b-
carboxyl of aspartic acid to minimize aspartimide formation.66 Cleavage of the 29-residue 
peptide from the resin using an improved HF procedure67 provided crude synthetic glucagon in 
75% yield.  A one-step purification using preparative C18 reverse-phase chromatography gave 
pure material (48% overall yield), which was crystallized from aqueous solution at pH 9.2.  The 
overall 48% isolated yield of homogeneous glucagon based on the starting C-terminal residue is 
much higher than the yield obtained in the earlier stepwise solid-phase synthesis of glucagon in 
which more acid-labile protecting groups were used.64 It is also higher than the yield reported for 
synthesis by solution methods.60,61 The high yield obtained in the synthesis and the subsequent 
ease of purification of synthetic glucagon made it feasible for the first time to approach structure-
function studies of the glucagon molecule through the total synthesis of selected analogues in a 
rapid and cost-effective manner.   
Over 200 analogues (agonists, antagonists) of glucagon had been synthesized in the Merrifield 
laboratory by 2006. An overview of research probing the glucagon receptor has been provided 
by Cecilia Unson, Bruce's long term collaborator and colleague for 28 years.68
Presently, a 1 to 2 person-week of effort is  required for the preparation and purification of a 
glucagon analogue using the chemistry outlined above.69
Again, to belabor the very obvious, a comparable study of structure-function relationships based 
on the availability of glucagon analogues from solution synthesis 60,61 is unthinkable with respect 
to manpower, cost and time required.  This is precisely why Bruce Merrifield invented SPPS 
and his colleagues labored to improve upon the method as originally conceived.
What about the SPPS of peptides larger than glucagon, say 90 to 100 residues?  Steve Kent and 
co-workers carefully re-examined the synthetic protocols used with PAM resins and introduced 
in situ neutralization into SPPS using Boc/Benzyl chemistry  for the rapid, efficient synthesis of 
difficult sequences.70 In addition, several side reactions were examined and eliminated.  The 
resulting improved chemistry and protocols were utilized in the synthesis of the L and D 
enantiomers of the 99 residue HIV-1 protease (1-99).71 Whether PAM resins with more 
improved chemistry can be routinely employed for the synthesis of peptides ≥ 90 to 100 residues 
remains to be established.  However, the development of native chemical ligation methods where 
purified fragments without side-chain protection can be coupled together has provided strategies 
for the synthesis of larger peptides (> 100 residues).72,73 Recently, Torbeev and Kent reported 
the covergent chemical synthesis of a 203 residue "Covalent Dimer" of HIV-1 protease enzyme 
using  native chemical ligation methods.  The resulting enzyme molecule showed full catalytic 
activity and a high resolution crystal structure was reported.74 In that PAM resins were used to 
produce the free acarboxyl fragments employed in this synthesis, it is pleasing to know that there 
is still a role for a resin support developed over 30 years ago in the Merrifield laboratory.
Other projects
The Merrifield group meetings usually occurred every Monday at 1 PM when students, postdocs 
and guest investigators presented their experimental findings, problems, and ideas.  It was also a 
good opportunity to candidly run inexplicable results past the group for comments and insight. 
Collaborations resulted when 2 or 3 members of the group were attracted to problems of mutual 
interest.  These efforts were usually informal, short term and provided pleasant respites from 
some of the longer-term work described earlier (vide supra).
Mechanisms and Prevention of Trifluoroacetylation in SPPS
In a study on the occurrence of trifluoroacetylation in SPPS I had observed that when a sample 
of Boc-Lys(Z)-OCH2-resin was deprotected (TFA), neutralized (tertiary amine) and cleaved 
(HBr-TFA or HF) a low level of Na-trifluoroacetyl-lysine (~ 1%) was observed.  When Z-
Lys(Boc)-OCH2-resin was treated in identical fashion, Ne-trifluoroacetyl-lysine (~10%) was 
observed.  Repetition of the deprotection, neutralization and cleavage steps again gave 
trifluoroacetyl-lysine products.   When neutralization was omitted, no trifluoroacetyl-lysine 
products were observed.  Also, when a primary amine was used for neutralization the production 
of trifluoroacetyl-lysine products was suppressed.  Both of the resins were prepared from a 
chloromethyl-resin by the cesium salt procedure.75  Trifluoroacetylation in the absence of a 
coupling step ran contrary to conventional wisdom which held that residual TFA, whatever the 
source, must be activated (DCC or other activating reagents) to allow for subsequent 
trifluoroacetylation of a-amino groups in SPPS.76 Steve Kent, joined by Martin Engelhard, 
tackled the project in a very detailed, thorough manner and conclusively showed that 
trifluoroacetylation occurred when hydroxymethyl groups were present in the resin.77 The 
esterification of hydroxymethyl-resins occurs upon standing in TFA and is observed by the 
appearance of a band at 1785 cm-1 in the IR.  The formation of trifluoroacetoxymethyl-resin and 
transfer of the TFA group to free Na-amino group during neutralization is shown in Figure 19.  
Hydroxymethyl groups can be preexisting (as in some commercial resins) or they can be formed 
during SPPS by the slow loss of peptide chains during deprotection steps.  About 1 to 2 % of 
TFA peptide is generated per synthetic cycle when conventional peptidyl-OCH2-resins are used.  
Use of the more acid stable peptidyl-PAM-resin, which is free of hydroxyl groups, reduces Na-
trifuoroacetylation to < 0.02 % per synthetic cycle. Since peptidyl-PAM-resins are 100 times 
more acid-stable than conventional peptidyl-OCH2-resins, the generation of new hydroxymethyl 
sites is greatly suppressed.
Tests for racemization
Reports suggesting that low levels of racemization occur during the stepwise synthesis of 
peptides78 prompted the search for a sensitive model to test such claims.  Kent and Mitchell 
teamed with George Barany, the youngest ever graduate student at Rockefeller University, to 
develop a sensitive test for the occurrence of racemization during SPPS.79 Diastereomers of the 
model peptide H-Leu-Ala-Gly-Val-OH were prepared and chromatographed on a standard amino 
acid analyzer using a single column of sulfonated polystyrene resin with ninhydrin detection.  
The single D-amino acid diastereomers, H-L-Leu-D-Ala-Gly-L-Val-OH and H-D-Leu-L-Ala-
Gly-L-Val-OH, were separated from one another and from the all L-amino acid tetrapeptide. The 
determination of the D-amino acid- containing diastereomers was accurate ≥ 0.1 % for a loading 
of 4 mmol of tetrapeptide and the limit of detection was less than 0.01% for a 12-mmol loading.  
The analysis was applied to the crude cleavage products obtained from the stepwise synthesis of 
Leu-Ala-Gly-Val and no D-amino acid-containing diastereomers were detected (<0.02 %).  The 
model system developed here can be used to study racemization in both solution and solid phase 
methods of peptide synthesis. 
In a related study we modified the Manning-Moore procedure11 used to establish the 
stereochemical purity of D- and L-amino acids and derivatives prepared from these amino 
acids.79 The chemical synthesis of optically pure peptides requires starting materials that have 
high stereochemical purity, hence the need for a procedure that allows the detection and 
quantitation of less than one part D-amino acid in the presence of 1000 parts L-amino acid. The 
Manning-Moore procedure, designed for the precise determination of the D and L isomers in a
given sample of a amino acid, is based upon chromatographic separation of the diastereoisomeric 
dipeptides obtained by derivatization with an L-amino acid N-carboxyanhydride (NCA). The 
derivatization step is rapid, proceeding in 2 min at pH 10.4 in about 90% yield.  Conditions of 
elution are known for each of 21 individual amino acids and the resulting pairs of LD and LL 
dipeptides on a  amino acid analyzer using ion exchange chromatography.  L-leucine N-
carboxyanhydride (L-Leu NCA) is used to prepare, without racemization, [L-Leu1]dipeptides of 
the acidic and neutral amino acids. The [L-Leu1]dipeptides of the aromatic and basic amino acids 
are strongly retarded on the amino acid column and glutamic acid NCA is used to prepare 
resolvable dipeptides of these amino acids. Under the proper conditions as little as 0.01% of the 
opposite enantiomer can be detected in an amino acid.  The success of the Manning-Moore 
procedure is contingent upon the availability of L-Leu NCA and L-Glu NCA.  Although we had 
used the Manning-Moore procedure with considerable success,81 the syntheses of L-Leu NCA 
and L-Glu NCA require the use of phosgene (poison gas in WWI) and give variable yields. In 
addition, the commercial availability of these labile compounds had been erratic. Also, L-Glu 
NCA and L-Leu NCA deteriorate at room temperature and must be stored dry at -20o C to retard 
decomposition and polymerization.  We replaced both L-Glu NCA and L-Leu NCA with the 
readily prepared and commercially available Boc-L-leucine N-hydroxysuccinimide ester (Boc-L-
Leu-OSu). Boc-L-Leu-OSu reacts with amino acids to give diastereomeric [L-Leu1]dipeptides 
which are suitable, after deprotection in TFA, for chromatographic separation.  The standard 
protocol involves the reaction of  amino acid (1 equiv) with Boc-L-Leu-OSu (2 equiv) and 
sodium bicarbonate (2 equiv) in tetrahydrofuran-water  (1:1) at room  temperature for 1 h, 
followed by trifluoroacetic acid deprotection.  The stock solution of Boc-L-Leu-OSu in 
tetrahydrofuran is stable at room temperature for at least 1 week, and at least 1 month if stored at 
4o C. Coupling yields, as measured by the disappearance of amino acid, varied from 94.5 to 
99.8% without detectable racemization (< 0.1%).  A larger excess Boc-L-Leu-OSu (10 equiv) 
was employed in the conversion of DL-lysine to NaNe-(di-L-Leu)-DL-Lys, which gave a 
coupling yield of 97 %. As the separation of the [L-Leu1]dipeptides containing acidic or neutral 
D- and L-aminoacids had already been reported,11,81 it was necessary only to derive conditions 
for the separation of  the [L-Leu1]dipeptides containing the aromatic or basic D- and L-amino 
acids.  We achieved this by the use of shorter ion exchange columns and/or more basic buffers 
that allowed the detection of less than one part (0.1%) of D-amino acid in the presence of 1000 
parts of L-amino acid.80
Quantitative Evaluation of Methods for Coupling Asparagine in SPPS
The dehydration of amides to nitriles is known to occur with Na-protected asparagine and 
glutamine, both in solution and in solid-phase peptide synthesis, during coupling with DCC, 
mixed anhydride, pyrophosphite, and other activation methods.  Dehydration occurs while these 
amino acids are activated and not during subsequent coupling steps after asparagine or glutamine 
has been incorporated. The proposed mechanism for dehydration involves nitrile compound 
formation through a cyclic isoimide intermediate.82 Dehydration had been shown to be prevented 
when 1-hydroxybenzotriazole was added together with DCC for activation and coupling of Nw-
protected asparagine and glutamine in solution83 and solid phase synthesis.84 As the sensitivity of 
detection for dehydration in these studies was > 5%, there was a definite need to know the extent 
of this reaction at the 0.1% level and also how to best avoid this reaction during SPPS of 
molecules such as glucagon that contain asparagine and glutamine.64,65
Svetlana Mojsov and I developed a quantitative procedure employing ion exchange 
chromatography to detect the formation of b-cyanoalanylglycine and other side products (b-
aspartamidinoacetic acid, a-aspartylglycine, b-aspartylglycine) resulting from the coupling of 
Boc-Asn to Gly-resins.85 Coupling of Boc-Asn with Gly-OCH2-(1,4-phenylene)-OCH2-resin 
(Wang resin) using DCC gave Asn-Gly (54.8%), Ala(CN)-Gly (39.2%) and b-aspartamidino 
acid (5.5%) after TFA cleavage. Activation of Boc-Asn by DCC plus hydroxybenzotriazole or 
by the nitrophenyl ester gave 98 to 99% of Asn-Gly with low levels of byproducts (0.5% nitrile 
and 0.2% amidine).  The use of Boc-Asn with the 4,4'-dimethoxybenzhydryl amide protecting 
group completely prevented nitrile formation during DCC coupling. Pure Ala(CN)-Gly 
quantitatively reconverts to Asn-Gly by HF treatment and rehydration of the nitrile group also 
occurs in 50% TFA in CH2Cl2, but much more slowly.
Postscript
I returned to California to work at Lawrence Livermore National Laboratory (LLNL) after 8 very 
interesting years in the Merrifield laboratory (1969-1977).  I left with mixed emotions as Steve 
Kent and I were preparing to undertake the first synthesis of an all-D enzyme, specifically the 
124 residue D-RNase A (see pp. 139-141 in reference 1).  D-RNase A was never synthesized as, 
and this is my conjecture, the technology to accomplish such a feat was immature at the time.  
Later, however, Steve and colleagues elsewhere accomplished a similar goal by synthesizing the 
L and D enantiomers of the 99 residue HIV-1 protease using stepwise SPPS.71
My initial years at LLNL involved the synthesis of fluorescent peptide substrates (peptidyl-
aminocoumarins) for the sensitive detection of various proteases.86,87 These materials could only 
be prepared using solution chemistry. A collaboration with Julio Camarero (LLNL) 25 years 
later made the peptidyl-aminocoumarins and related materials accessible by SPPS.88,89 Although 
the bulk of my time at LLNL has been devoted to energetic materials research, I have maintained 
an interest in peptide chemistry and kept in frequent contact with Bruce over the years. I was 
greatly honored when Bruce asked me to critically review the manuscript for his scientific 
biography, Life During a Golden Age of Peptide Chemistry. The Concept and Development of 
Solid-Phase Peptide Chemistry (see p. 253 in reference 1).
Bruce Merrifield
How to best describe the man and his science?  Garland Marshall assessed the scientific impact 
of Bruce's work in his incisive review "Solid-Phase Synthesis: A Paradigm Shift".2 Solid-phase 
synthesis as used for the synthesis of biopolymers (peptides, proteins, nucleic acids), synthesis of 
natural products, chemical ligation and materials development has indeed provided a paradigm 
shift in the molecular biology, biotechnology and chemistry communities.
The man who emerges from the pages of Life During a Golden Age of Peptide Chemistry, and 
the man his colleagues knew and respected, was tough and dedicated but also caring and modest.  
He deeply cared about his two families, the family at home and the family in the laboratory (see 
pp. 208-227 in reference 1).  Libby Merrifield, his wife, friend and colleague for over 55 years 
provided the bedrock for his career.   He did not voice anger when the early critics maligned him 
and his work, just as he did not complain about a long-term progressively invasive skin cancer 
and the increasingly draconian medical treatments.  It would have been out of character and a 
waste of energy that could be better used in the laboratory.  Early in 2003, prior to the final 
combinations of treatments (surgery, chemotherapy, and radiation), I asked Bruce if he had 
considered retirement as an option.  He smiled and said, "sure, I think I'll retire just about 2 
minutes before I drop dead in the lab."  Bruce, thank you for your life, your work and your 
inspiration to all who knew you.
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Figure 1. Acylation of peptide bonds followed by aminoacyl insertion as postulated by 
Brenner.6,7
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Figure 2. Model system to test amino acid insertions during SPPS.8
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Figure 3. Proposed enzyme model with peptide bridges between p-aminobenzoyl residues to 
allow placement of functional side chains.3-5
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Figure 4. Synthesis of cyclic peptides using polynitrophenol supports.17
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Figure 5. General scheme for the SPPS of homodetic cyclic peptides.
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Figure 6. Use of mercaptophenol resin for the SPPS of cyclic peptides.23
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Figure 7. Comparative cyclizations of peptidyl-diazenes in solution and from a resin support 
according to Wieland.25
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Figure 8. Proposed synthesis of cyclic peptides using a catechol resin.
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Figure 9. Friedel-Crafts reaction of catechol or o-benzyloxyphenol with chloromethyl resin to 
provide catechol resin.
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Figure 10. Comparison of cyclizations of Pro3 using catechol and nitrophenol supports and 
solution synthesis.
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Figure 11. Ocurrence of N-alkylation during the acidolytic cleavage of Boc-protecting group.
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Figure 12. Model system for the detection of Na-tert-butylation and Ne-benzylation during 
SPPS.
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Figure 13. General scheme for measuring synthetic efficiency of SPPS as a function of chain 
length.
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Figure 14. Determination of synthetic efficiency of SPPS using phenylhydrazine resin. PHBA is 
p-hydrazinobenzoic acid.
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Figure 15. Use of PAM-resin to investigate synthetic efficiency in SPPS.
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Figure 16. General preparation of Boc-aminoacyloxymethyl-PAM-resins using 4-
(acetoxymethyl)phenyl acetic acid.
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Figure 17. General preparation of Boc-aminoacyloxymethyl-PAM-resins using 4-
(halomethyl)phenyl acetic acid (X= Cl, Br).
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Figure 18.  General preparation of Boc-aminoacyl-4-(oxymethyl)phenyl acetic acids.
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Figure 19. Formation of trifluoroacetoxymethyl-resin and transfer of trifluoroacetyl group to 
Na-amino groups during neutralization.
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